Ann Lab Med.  2014 Jan;34(1):64-65. 10.3343/alm.2014.34.1.64.

Comments on Point of Care D-Dimer Testing in the Emergency Department: A Bioequivalence Study

• Ekelund S
• Heilmann E

• KMID: 1781363
• DOI: http://doi.org/10.3343/alm.2014.34.1.64

Abstract

No abstract available.

MeSH Terms

Female
Fibrin Fibrinogen Degradation Products/*analysis
Humans
Male
Venous Thromboembolism/*diagnosis
Fibrin Fibrinogen Degradation Products

Reference

1. Perveen S, Unwin D, Shetty AL. Point of care D-dimer testing in the emergency department: a bioequivalence study. Ann Lab Med. 2013; 33:34–38. PMID: 23301220.

2. Goodacre S, Sampson FC, Sutton AJ, Mason S, Morris F. Variation in the diagnostic performance of D-dimer for suspected deep vein thrombosis. QJM. 2005; 98:513–527. PMID: 15955795.

3. Coen Herak D, Milos M, Zadro R. Evaluation of the Innovance D-DIMER analytical performance. Clin Chem Lab Med. 2009; 47:945–951. PMID: 19548843.

4. Sukhu K, Beavis J, Baker PM, Keeling DM. Comparison of an immuno-turbidometric method (S Talia D-DI) with an established enzyme linked fluorescent assay (VIDAS) D-dimer for the exclusion of venous thromboembolism. Int J Lab Hematol. 2008; 30:200–204. PMID: 18479298.

5. Sidelmann JJ, Gram J, Larsen A, Overgaard K, Jespersen J. Analytical and clinical validation of a new point-of-care testing system for determination of D-Dimer in human blood. Thromb Res. 2010; 126:524–530. PMID: 20846709.